Market closed
CervoMed Inc./$CRVO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Ticker
$CRVO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
15
Website
CervoMed Inc. Metrics
BasicAdvanced
$98M
-
-$2.02
-
-
Price and volume
Market cap
$98M
52-week high
$16.94
52-week low
$1.92
Financial strength
Current ratio
11.106
Quick ratio
10.614
Management effectiveness
Return on assets (TTM)
-42.94%
Return on equity (TTM)
-69.95%
Valuation
Price to revenue (TTM)
9.318
Price to book
2.5
Price to tangible book (TTM)
2.5
Price to free cash flow (TTM)
-5.489
Growth
Revenue change (TTM)
36.29%
Earnings per share change (TTM)
147.27%
3-year earnings per share growth (CAGR)
29.99%
CervoMed Inc. News
AllArticlesVideos
Biotech Stocks Q1 2025 Recap: Winners And Underperformers
Seeking Alpha·5 days ago
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™)
GlobeNewsWire·2 weeks ago
CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats
Seeking Alpha·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CervoMed Inc. stock?
CervoMed Inc. (CRVO) has a market cap of $98M as of April 05, 2025.
What is the P/E ratio for CervoMed Inc. stock?
The price to earnings (P/E) ratio for CervoMed Inc. (CRVO) stock is 0 as of April 05, 2025.
Does CervoMed Inc. stock pay dividends?
No, CervoMed Inc. (CRVO) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next CervoMed Inc. dividend payment date?
CervoMed Inc. (CRVO) stock does not pay dividends to its shareholders.
What is the beta indicator for CervoMed Inc.?
CervoMed Inc. (CRVO) does not currently have a Beta indicator.